Pacemaker after heart procedure for atrial fibrillation
Part of Heart & circulation clinical trials.
This trial tests a new type of pacemaker for people with atrial fibrillation who are scheduled for a procedure that disconnects the heart's natural electrical pathway. It may help improve symptoms and heart function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have atrial fibrillation that causes symptoms like palpitations, shortness of breath, or fatigue despite current treatments
- Your heart's pumping strength is normal (ejection fraction 50% or higher)
- You are already planning to have a procedure called AV node ablation
- You are 18 years or older
- You do not have a pacemaker already implanted
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a pacemaker plus an ablation procedure can improve heart failure symptoms in people with atrial fibrillation. It is for those with moderate to severe heart failure who are already on the right medications.
This study is testing two new ways of pacing the heart to see if they can reduce the chance of developing atrial fibrillation (an irregular heartbeat). It might be a good fit if you need a pacemaker for a slow heart rate but have never had atrial fibrillation before.
This trial tests a special pacing method (conduction system pacing) combined with a small ablation to control heart rate in people with permanent atrial fibrillation and advanced heart failure. It aims to improve symptoms and potentially avoid the need for a heart transplant or LVAD.
This trial studies whether a strategy to regularize (control) heart rate can improve outcomes in people who have permanent atrial fibrillation and heart failure. It focuses on people with recent heart-failure hospitalization and checks several heart, kidney, and health-condition limits to keep the study safe.
This study tests a new type of catheter ablation (a procedure that uses energy to treat irregular heartbeats) for atrial fibrillation—a common heart rhythm problem. You may qualify if you have recurring irregular heartbeats that haven't responded well to heart medications and are planning to have this procedure.
This trial tests a new catheter system to treat atrial fibrillation (AF) by creating small scars in the heart to block faulty signals. It may help people with symptoms that continue despite medication and who are scheduled for a standard ablation procedure.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.